Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis [Phase 1]
A Phase 1 study evaluating safety, tolerability, and pharmacokinetics of GS-5745 (andecaliximab) in patients with rheumatoid arthritis has c…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) [Phase 2]
This document provides an update on the Phase 2 efficacy and safety study of Mizoribine in active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Pilot Study of Ultrasound in Rheumatoid Arthritis
The document notes the completion of a pilot study evaluating the use of ultrasound in rheumatoid arthritis. It confirms the trial status as…
-
FDA approval · 2015-06-19FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) submitted by Pfizer Laboratories Div Pfizer Inc. The approval updates the …
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 3]
A Phase 3 randomized, double-blind study evaluating T-614 in combination with methotrexate in rheumatoid arthritis patients with inadequate …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: GIOP Prevention Among People With Rheumatoid Arthritis [NA]
A clinical trial update indicates completion of a study on preventing glucocorticoid-induced osteoporosis in people with rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis
This document reports the long-term investigation of adalimumab (Humira) in patients with rheumatoid arthritis, including results posted in …
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor [Phase 3]
A Phase 3 trial of MabThera (rituximab) in rheumatoid arthritis patients who had an inadequate response to a single anti-TNF inhibitor has c…
-
FDA approval · 2015-06-09FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' Original Application for celecoxib, enabling a generic version of Celecoxib to enter the market.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial sponsored by University College Cork to determine the effects of exercise in people with inflammatory bowel disease…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003) [Phase 2]
Phase 2 trial of No-Rofecoxib plus aspirin for arthritis patients undergoing endoscopy was terminated.
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)
The clinical trial NCT01313871 evaluating rheumatoid arthritis disease severity and treatment patterns in Eastern Europe, the Middle East an…
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
A study of immune cell responses in rheumatoid arthritis patients during different anti-TNF alpha therapies was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
A completed trial assessed the impact of adalimumab on extraarticular bone health (bone metabolism and bone mineral density) in patients wit…
-
CLINICAL_TRIALS research · 2015-05-29Clinical Trial Update: Exercise-induced Improvements of Inflammatory Status in Patients With Rheumatoid Arthritis [NA]
Completed clinical trial evaluating exercise-induced improvements in inflammatory status among patients with rheumatoid arthritis, reporting…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients
Clinical trial evaluating the presence of autoantibodies to gastric parietal cells in rheumatoid arthritis patients with vitamin B12 deficie…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy [Phase 4]
Phase 4 clinical trial update examining optimal management of rheumatoid arthritis patients requiring biologic therapy; the trial status is …
-
FDA approval · 2015-05-28FDA Approved: SULINDAC — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
The FDA approved a supplemental application for sulindac from PuraCap Laboratories dba Blu Pharmaceuticals, updating the product’s labeling …
-
CLINICAL_TRIALS withdrawal · 2015-05-28Clinical Trial Update: Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA) [Phase 1]
A Phase 1 trial examining the effect of tranilast on the pharmacokinetics of methotrexate in rheumatoid arthritis patients has been withdraw…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 study demonstrates pharmacokinetic equivalence between CT-P10 and MabThera (rituximab) in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis [Phase 4]
This clinical trial update reports on an uncontrolled Phase 4 study evaluating the efficacy of tocilizumab in patients with moderate to seve…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107) [Phase 3]
Phase 3, two-part, 12-week trial of etoricoxib for rheumatoid arthritis has completed and results were posted on 2015-05-21.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis [Phase 2]
A Phase 2 dose-finding study of aminopterin in methotrexate-naïve rheumatoid arthritis has completed. The trial was sponsored by Syntrix Bio…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept [Phase 4]
Phase 4 trial comparing autoinjector preferences in patients with rheumatoid arthritis and plaque psoriasis treated with etanercept; results…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor [Phase 2]
A Phase 2 study of VX-509 (decernotinib), a JAK3 inhibitor, in active rheumatoid arthritis, including an MRI study and arthroscopic biopsy s…